GV

What they fund

• AI-Native Startups — GV funds seed to growth-stage companies building agentic systems, AI coding agents, and multimodal platforms [1].
• Healthcare & Life Sciences — GV invests in AI healthcare companies accelerating drug discovery, such as insitro and Isomorphic Labs [1].
• Dev Tools & Security — GV backs companies providing picks and shovels for AI, including dev tools and security solutions like Vercel and Stackblitz [1].
• AI Infrastructure — GV invests in the infrastructure layer of AI, including photonic computing, hardware-software platforms, and inference companies [1].

Credibility: GV's website details its investment focus on AI-native applications, healthcare AI, dev tools, and infrastructure, naming specific portfolio companies [1].

Investment thesis

GV operates as a financially driven venture fund with Alphabet as its single LP, explicitly rejecting the typical corporate VC model of investing mainly for strategic alignment with the parent company rather than pure returns, and became one of the earliest corporate-backed funds to aggressively invest in direct competitors to its parent company [1].

• AI-Native Application Layer — GV backs the next generation of AI-native applications, specifically targeting agentic systems, AI coding agents, and multimodal platforms, with a conviction that the fastest-growing companies are at the application layer — from Harvey and Hebbia in professional AI workflows to Synthesia in generative video [1].
• Healthcare AI & Life Sciences — Healthcare AI is reshaping science, and GV has partnered with 20 AI healthcare companies, including insitro and Isomorphic Labs, using AI to accelerate drug discovery and improve patient outcomes [1].
• Dev Tools & Security — GV invests in the "picks and shovels" of AI, backing dev tools and security companies that reduce time-to-market for AI solutions, including breakouts like Stackblitz (Bolt.new) and Vercel [1].
• AI Infrastructure — Early conviction in the infrastructure layer of AI led to investments in photonic computing, hardware-software platforms, and inference companies like Snorkel, Deepset, SambaNova, Modular, and Lightmatter [1].

Credibility: GV's own website details its portfolio clusters and strategic conviction in AI-native applications, healthcare AI, and infrastructure [1].

Value add

GV provides portfolio companies with access to operational help after making a financial investment. Full-time partners work with portfolio companies on design and product management, marketing, engineering, and recruiting [2]. GV also developed an intensive, five-day design process called a Design Sprint, which helps startups solve problems quickly based on agile development and design thinking [2].

Fit verdict: GV is a strong fit for AI-native startups requiring operational support in design, product, and engineering, as well as access to Alphabet's resources.

Founder diligence script:

• How does GV's Design Sprint process integrate with our product development cycle?
• What specific operational support can we expect from GV's full-time partners in engineering and recruiting?
• How does GV's access to Alphabet's resources translate into tangible benefits for our startup?
• What is GV's typical follow-on investment posture for portfolio companies?
• How does GV measure success for its portfolio companies beyond financial returns?

Credibility: Wikipedia details GV's operational support, Design Sprint process, and partner involvement [2].

Portfolio focus

• AI-Native Applications — GV has backed 50+ companies at AI's frontier, including agentic systems and multimodal platforms like Harvey, Hebbia, and Synthesia [1].
• Dev Tools & Infrastructure — The portfolio includes foundational AI infrastructure and dev tools like Vercel, Stackblitz (Bolt.new), Snorkel, Deepset, SambaNova, Modular, and Lightmatter [1].
• Healthcare AI — GV has partnered with 20 AI healthcare companies, including insitro and Isomorphic Labs, focusing on AI-driven drug discovery and patient care [1].

Credibility: GV's website explicitly lists these portfolio companies as examples of its AI-native, dev tool, and healthcare AI investments [1].

Notable investments & exits

• Uber — GV invested in Uber, which went public in 2019 [2].
• Nest — GV invested in Nest, which was acquired by Google in 2014 [2].
• Slack — GV invested in Slack, which was acquired by Salesforce in 2021 [2].
• Stripe — GV invested in Stripe, which remains a private company [2].
• Flatiron Health — GV invested in Flatiron Health, which was acquired by Roche in 2018 [2].

Credibility: Wikipedia lists these notable exits and investments in GV's portfolio [2].

Strategic implications

GV's single-LP structure with Alphabet provides a stable capital base for long-term investments, allowing it to take patient, high-conviction bets on AI-native startups and healthcare AI. GV's focus on pure returns and aggressive investment in direct competitors to its parent company distinguishes it from typical corporate VCs, making it a unique and valuable partner for founders. GV's operational support, including its Design Sprint process and full-time partners, provides tangible value to portfolio companies, enhancing their chances of success. GV's recent focus on AI-native startups and healthcare AI positions it at the forefront of two of the most transformative trends in technology and healthcare.

Where they could go further

GV could expand its focus on AI-native startups in emerging markets, such as Southeast Asia and Latin America, to capture high-growth opportunities in these regions. GV could develop a more structured program for supporting portfolio companies in regulatory and compliance matters, particularly in the healthcare AI space. GV could enhance its operational support by providing more targeted resources for scaling engineering and product teams, given the technical complexity of AI-native startups. GV could explore new investment themes beyond AI, such as climate tech and space tech, to diversify its portfolio and capture emerging opportunities.